“Global in vitro diagnostics market valued at $101,058.9M in 2024, reached $109,065.5M in 2025, and is projected to grow at a robust 7.6% CAGR, hitting $157,632.5M by 2030.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703&utm_source=reportsnreports.com&utm_medium=refferal&utm_campaign=kk27
Point-of-Care (PoC) Diagnostics Growth: The IVD market is seeing a major shift towards PoC technologies. Driven by the demand for rapid, accurate, and accessible testing, PoC diagnostics are increasingly adopted in various settings outside of traditional laboratories, including hospitals, clinics, and home-based care.
Rise of Molecular Diagnostics: Advancements in molecular diagnostics, including DNA sequencing and Next-Generation Sequencing (NGS), are driving growth. These technologies are seeing increasing application in research, drug discovery, and diagnostics, particularly in areas like cancer and genetic disorder detection.
Increased Adoption of Automation: The market is trending toward greater lab automation, with increasing adoption of automated analyzers. This focus on automation aims to make laboratory processes more efficient, streamlined, and capable of handling higher test volumes across various clinical settings.
Digital Diagnostics and AI Integration: IVD players are increasingly focusing on digital diagnostics as a path for future growth, moving beyond simple testing to integrate data and technology. This includes pairing real-time data from devices with services for clinical management guidance and using AI-driven analytics to illuminate insights in the data.
Focus on Personalized and Precision Medicine: IVD tests, such as genetic testing, are essential components in the shift toward personalized treatment. The industry is utilizing diagnostics for early detection, regular monitoring, and identifying personalized treatment pathways, catering to conditions like diabetes and cancer.
Growing Demand for Reagents and Kits: The reagents and kits segment is a significant part of the IVD market, with growth fueled by the rise in test volumes across clinical labs, hospitals, and PoC settings. These consumables, ranging from simple blood analysis reagents to complex molecular diagnostic reagents, are critical for IVD testing.
Expansion in Infectious Diseases Testing: Infectious diseases remain a dominant application segment in the IVD market. The ongoing demand for sophisticated and rapid testing solutions, often incorporating technologies like immunoassays, continues to drive innovation and market share in this area.
Emergence of Companion Diagnostics: The use of IVD products in clinical drug development and companion diagnostics is growing. These diagnostics are crucial for determining a patient’s likely response to a specific drug therapy, making them vital for personalized medicine strategies.
Growth in the Asia Pacific Region: The Asia Pacific market is emerging as the fastest-growing region for IVD, attributed to significant growth in key countries like China, Japan, and India. The region offers substantial growth opportunities for IVD players.
Strategic Partnerships and Collaborations: Industry players are actively forming strategic partnerships with academic institutions and technology providers to accelerate innovation and expand market reach. Collaborative efforts are seen as a key strategy to develop and commercialize new IVD solutions.”